To explore the potential clinical use of ZSWIM4-targeted inhibitors, tumor tissues exhibiting ZSWIM4 expression from two patients with EOC were obtained to construct PDO models (Fig. 8A). The gene discussed is ZSWIM4; the disease is neoplasm.